TRUMENBA
Google image searchProduct monograph
Active ingredients
neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a, 60 MCG/0.5 ML
neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b, 60 MCG/0.5 ML
DIN: 02468751
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Description: BIVALENT RECOMBINANT LIPOPROTEIN (RLP2086) - PREFILLED SYRINGE
Schedule: Schedule D
Company: PFIZER CANADA ULC
Date: 31-JAN-2018
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07A — BACTERIAL VACCINES (ATC, ATC/DDD)
- J07AH — Meningococcal vaccines (ATC, ATC/DDD)
External Links for Trumenba
Search on Google
- Trumenba side effects
- Trumenba dosage
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a side effects
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily a dosage
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b side effects
- neisseria meningitidis grp b recombinant lipoprotein 2086 subfamily b dosage
